1. SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F. (17th April 2013) Authors: Koren‐Michowitz, Maya; Gery, Sigal; Tabayashi, Takayuki; Lin, Dechen; Alvarez, Rocio; Nagler, Arnon; Koeffler, H. Phillip Journal: British journal of haematology Issue: Volume 161:Number 6(2013:Jun.) Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗